Evidence map›Paper›PMID 36566348›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2023

Modulation of NLRP3 inflammasomes activation contributes to improved survival and function of mesenchymal stromal cell spheroids.

Duc-Vinh Pham, Prakash Shrestha, Thi-Kem Nguyen, Junhyeung Park, Mahesh Pandit, Jae-Hoon Chang, Soo Young Kim, Dong-Young Choi, Sung Soo Han, Inho Choi and 3 more

Open access · greenAbstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Duc-Vinh PhamCollege of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea; Department of Pharmacology, Hanoi University of Pharmacy, Hanoi, Viet Nam.
Prakash ShresthaDepartment of Precision Medicine, School of Medicine, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Thi-Kem NguyenCollege of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea.
Junhyeung ParkDepartment of Precision Medicine, School of Medicine, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Mahesh PanditCollege of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea.
Jae-Hoon ChangCollege of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea.
Soo Young KimCollege of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea.
Dong-Young ChoiCollege of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea.
Sung Soo HanResearch Institute of Cell Culture, Yeungnam University, Gyeongsan 38541, Republic of Korea; School of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea.
Inho ChoiResearch Institute of Cell Culture, Yeungnam University, Gyeongsan 38541, Republic of Korea; Department of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, Republic of Korea.
Gyu Hwan ParkCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.
Jee-Heon JeongDepartment of Precision Medicine, School of Medicine, Sungkyunkwan University, Suwon 16419, Republic of Korea. Electronic address: jeeheon@skku.edu.
Pil-Hoon ParkCollege of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea; Research Institute of Cell Culture, Yeungnam University, Gyeongsan 38541, Republic of Korea. Electronic address: parkp@yu.ac.kr.
Yeungnam University · KRSungkyunkwan University · KRHanoi University of Pharmacy · VNKyungpook National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) are ubiquitous multipotent cells that exhibit significant therapeutic potentials in a variety of disorders. Nevertheless, their clinical efficacy is limited owing to poor survival, low rate of engraftment, and impaired potency upon transplantation. Spheroidal three-dimensional (3D) culture of MSCs (MSC

Indexed as

ColitisInflammasomesMesenchymal Stem CellsAnimalsCell Culture Techniques, Three DimensionalMiceNLR Family, Pyrin Domain-Containing 3 ProteinSignal TransductionInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseautophagyER tressinflammasomesMSCspheroids

Identifiers

PMID36566348
PMCPMC10014231
OpenAlexW4312140427

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.